<?xml version="1.0" encoding="UTF-8"?>
<ref id="B114-viruses-11-00139">
 <label>114.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Mandell</surname>
    <given-names>R.B.</given-names>
   </name>
   <name>
    <surname>Koukuntla</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Mogler</surname>
    <given-names>L.J.</given-names>
   </name>
   <name>
    <surname>Carzoli</surname>
    <given-names>A.K.</given-names>
   </name>
   <name>
    <surname>Holbrook</surname>
    <given-names>M.R.</given-names>
   </name>
   <name>
    <surname>Martin</surname>
    <given-names>B.K.</given-names>
   </name>
   <name>
    <surname>Vahanian</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Link</surname>
    <given-names>C.J.</given-names>
   </name>
   <name>
    <surname>Flick</surname>
    <given-names>R.</given-names>
   </name>
  </person-group>
  <article-title>Novel suspension cell-based vaccine production systems for rift valley fever virus-like particles</article-title>
  <source>J. Virol. Methods</source>
  <year>2010</year>
  <volume>169</volume>
  <fpage>259</fpage>
  <lpage>268</lpage>
  <pub-id pub-id-type="doi">10.1016/j.jviromet.2010.07.015</pub-id>
  <pub-id pub-id-type="pmid">20655330</pub-id>
 </element-citation>
</ref>
